Immunovant, Inc. Gains 35.26%

Wed, May 20, 2026 at 07:41 PM

Immunovant, Inc. (IMVT:NASDAQ) jumped higher at $35.56, representing a gain of 35.3%. On Wed, May 20, 2026, IMVT:NASDAQ hit a New 2-Week High of $35.56. The stock appeared on our News Catalysts scanner on Wed, May 20, 2026 at 05:08 PM in the 'BIOTECH' category. From Wed, May 06, 2026, the stock recorded 40.00% Up Days and 45.45% Green Days

About Immunovant, Inc. (IMVT:NASDAQ)

Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes IMVT-1401 targets the neonatal Fc receptor (FcRn).

Top 10 Gainers:

HCW Biologics Inc. (HCWB:NASDAQ), 129.25%
Silexion Therapeutics Corp (SLXN:NASDAQ), 96.95%
GCL Global Holdings Ltd (GCL:NASDAQ), 72.46%
BiomX Inc. (PHGE:NYSEMKT), 59.6%
MetaVia Inc. (MTVA:NASDAQ), 53.72%
Micware Co. Ltd. (MWC:NASDAQ), 51.48%
TDH Holdings, Inc. (PETZ:NASDAQ), 41.98%
MicroAlgo Inc. (MLGO:NASDAQ), 39.95%
Immunovant, Inc. (IMVT:NASDAQ), 35.26%
Rain Enhancement Technologies Holdco, Inc. (RAIN:NASDAQ), 34.67%